← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Bio-Techne
-4.09%
Healthcare & biotech / Biotechnology and Life Sciences Solutions
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
Bio-Techne is a global life sciences company that provides innovative research tools and solutions to scientists and clinicians. The company was established in 1976 and is headquartered in Minneapolis, Minnesota. It operates through four key divisions: Bio-Techne, R&D Systems, Novus Biologicals, and ProteinSimple.
Bio-Techne's products include proteins, antibodies, assays, and reagents for a wide range of research areas such as cell biology, immunology, neuroscience, and drug discovery. The company also offers services such as protein analysis, contract manufacturing, and custom antibody development.
Bio-Techne has a strong global presence, with offices and distribution centers in North America, Europe, and Asia-Pacific. It serves customers in over 160 countries and has collaborations with leading pharmaceutical and biotech companies.
The company is committed to advancing science and improving human health through its products and services. It invests heavily in research and development to continuously innovate and expand its product portfolio. Bio-Techne also supports the scientific community through educational initiatives and partnerships with academic institutions.
In addition to its research tools and solutions, Bio-Techne has a strong focus on corporate social responsibility and sustainability. It has implemented various initiatives to reduce its environmental impact and support the communities where it operates.
Overall, Bio-Techne is a leading company in the life sciences industry, known for its high-quality products, scientific expertise, and commitment to improving human health.
Bio-Techne's products include proteins, antibodies, assays, and reagents for a wide range of research areas such as cell biology, immunology, neuroscience, and drug discovery. The company also offers services such as protein analysis, contract manufacturing, and custom antibody development.
Bio-Techne has a strong global presence, with offices and distribution centers in North America, Europe, and Asia-Pacific. It serves customers in over 160 countries and has collaborations with leading pharmaceutical and biotech companies.
The company is committed to advancing science and improving human health through its products and services. It invests heavily in research and development to continuously innovate and expand its product portfolio. Bio-Techne also supports the scientific community through educational initiatives and partnerships with academic institutions.
In addition to its research tools and solutions, Bio-Techne has a strong focus on corporate social responsibility and sustainability. It has implemented various initiatives to reduce its environmental impact and support the communities where it operates.
Overall, Bio-Techne is a leading company in the life sciences industry, known for its high-quality products, scientific expertise, and commitment to improving human health.
What is special about the company?
1. Renowned Biotech Company: Bio-Techne is a globally recognized biotech company that specializes in providing innovative solutions for life science research, diagnostics, and clinical laboratories.
2. Diverse Product Portfolio: The company offers a diverse range of high-quality products including antibodies, proteins, assays, flow cytometry, imaging, and molecular biology reagents. This extensive product portfolio allows researchers and clinicians to access all the necessary tools for their work.
3. Cutting-edge Technology: Bio-Techne utilizes cutting-edge technology to develop and manufacture its products. This includes advanced protein and antibody engineering platforms, flow cytometry and imaging systems, and molecular and cell biology techniques.
4. Expertise in Multiple Disciplines: Bio-Techne has expertise in multiple disciplines such as immunology, cell biology, neuroscience, and molecular diagnostics. This allows the company to provide comprehensive solutions for a wide range of research areas.
5. Global Reach: With headquarters in the United States, Bio-Techne has a global presence with manufacturing facilities, distribution centers, and sales offices in multiple countries. This enables the company to serve customers all over the world.
6. Strong Scientific Collaborations: The company has strong collaborations with leading academic and research institutions, which allows them to stay at the forefront of scientific advancements and develop new products.
7. Commitment to Quality and Safety: Bio-Techne has a strict quality control system in place to ensure the safety and effectiveness of its products. They have obtained ISO 13485 certification and are compliant with FDA regulations.
8. Focus on Customer Service: The company has a customer-centric approach and is committed to providing exceptional customer service. They offer technical support, training, and customized solutions to meet the unique needs of their customers.
2. Diverse Product Portfolio: The company offers a diverse range of high-quality products including antibodies, proteins, assays, flow cytometry, imaging, and molecular biology reagents. This extensive product portfolio allows researchers and clinicians to access all the necessary tools for their work.
3. Cutting-edge Technology: Bio-Techne utilizes cutting-edge technology to develop and manufacture its products. This includes advanced protein and antibody engineering platforms, flow cytometry and imaging systems, and molecular and cell biology techniques.
4. Expertise in Multiple Disciplines: Bio-Techne has expertise in multiple disciplines such as immunology, cell biology, neuroscience, and molecular diagnostics. This allows the company to provide comprehensive solutions for a wide range of research areas.
5. Global Reach: With headquarters in the United States, Bio-Techne has a global presence with manufacturing facilities, distribution centers, and sales offices in multiple countries. This enables the company to serve customers all over the world.
6. Strong Scientific Collaborations: The company has strong collaborations with leading academic and research institutions, which allows them to stay at the forefront of scientific advancements and develop new products.
7. Commitment to Quality and Safety: Bio-Techne has a strict quality control system in place to ensure the safety and effectiveness of its products. They have obtained ISO 13485 certification and are compliant with FDA regulations.
8. Focus on Customer Service: The company has a customer-centric approach and is committed to providing exceptional customer service. They offer technical support, training, and customized solutions to meet the unique needs of their customers.
What the company's business model?
The Bio-Techne company's business model is focused on developing, manufacturing, and distributing high-quality life science reagents and instruments used in biomedical research and clinical diagnostics. This includes products such as antibodies, proteins, assay kits, and instruments for cell and gene therapy, immunotherapy, and molecular diagnostics. Bio-Techne sells its products directly to customers, as well as through distributors and OEM (original equipment manufacturer) partnerships. The company also provides contract research and manufacturing services for the development and production of custom reagents and assays. Additionally, Bio-Techne has strategic alliances and collaborations with other companies and organizations to advance research and innovation in the life sciences field.
Interesting facts about the company
1. Bio-Techne Corporation was founded in 1976 and was originally known as Techne Corporation.
2. The company started as a manufacturer of instruments used for immunodiagnostics, specifically for measuring cytokines and interferons.
3. In 1999, the company acquired R&D Systems, a leading supplier of proteins, antibodies, and immunoassay products. This acquisition marked the beginning of Bio-Techne’s expansion into the life sciences market.
4. Bio-Techne has a global presence, with operations in over 50 countries and customers in over 135 countries.
5. The company’s products are used in various fields such as medical research, drug development, and diagnostics.
6. Bio-Techne’s headquarters are located in Minneapolis, Minnesota, and it has manufacturing facilities in the United States, Canada, China, and Europe.
7. The company has over 3,800 employees worldwide.
8. In 2020, Bio-Techne was named one of the World’s Most Innovative Companies by Forbes magazine.
9. The company is listed on the NASDAQ stock exchange under the ticker symbol TECH.
10. Bio-Techne is committed to sustainability and has reduced its carbon emissions by 70% since 2015. It also has a program in place to reduce single-use plastic in its products and packaging.
11. In addition to its main areas of focus, Bio-Techne also offers custom manufacturing services for customers in the biotech industry.
12. The company has received multiple awards and recognition for its products and services, including the CiteAb award for Best Antibody Supplier and the Scientists’ Choice Award for Best New Life Sciences Product.
13. Bio-Techne is involved in various philanthropic efforts, including donating funds and products to support medical research and providing financial support for organizations working towards social justice and equality.
14. In 2021, Bio-Techne announced a partnership with the Bill and Melinda Gates Foundation to develop and manufacture a novel protein-based COVID-19 vaccine.
15. The company’s mission is to provide innovative tools and resources to advance the understanding of biology and to accelerate the discovery and development of new therapeutics.
See Company Due Diligence:
2. The company started as a manufacturer of instruments used for immunodiagnostics, specifically for measuring cytokines and interferons.
3. In 1999, the company acquired R&D Systems, a leading supplier of proteins, antibodies, and immunoassay products. This acquisition marked the beginning of Bio-Techne’s expansion into the life sciences market.
4. Bio-Techne has a global presence, with operations in over 50 countries and customers in over 135 countries.
5. The company’s products are used in various fields such as medical research, drug development, and diagnostics.
6. Bio-Techne’s headquarters are located in Minneapolis, Minnesota, and it has manufacturing facilities in the United States, Canada, China, and Europe.
7. The company has over 3,800 employees worldwide.
8. In 2020, Bio-Techne was named one of the World’s Most Innovative Companies by Forbes magazine.
9. The company is listed on the NASDAQ stock exchange under the ticker symbol TECH.
10. Bio-Techne is committed to sustainability and has reduced its carbon emissions by 70% since 2015. It also has a program in place to reduce single-use plastic in its products and packaging.
11. In addition to its main areas of focus, Bio-Techne also offers custom manufacturing services for customers in the biotech industry.
12. The company has received multiple awards and recognition for its products and services, including the CiteAb award for Best Antibody Supplier and the Scientists’ Choice Award for Best New Life Sciences Product.
13. Bio-Techne is involved in various philanthropic efforts, including donating funds and products to support medical research and providing financial support for organizations working towards social justice and equality.
14. In 2021, Bio-Techne announced a partnership with the Bill and Melinda Gates Foundation to develop and manufacture a novel protein-based COVID-19 vaccine.
15. The company’s mission is to provide innovative tools and resources to advance the understanding of biology and to accelerate the discovery and development of new therapeutics.
See Company Due Diligence:
Wait! There's more — sign up for free or log in